Link to: TAIWAN SPECIAL PUBLICATION ¥x ÆW ±M ¥Z  
Link to: HAKKA TAIWANESE SPECCIAL PUBLICATION «È ¥x »y ±M ¥Z ¦U ´Á
Link to:TAIWANESE HAKKA ¥x ÆW «È ®a (ENGLISH) 
Link to:HAKKA TAIWANESE RESOURCES «È ¥x »y ¸ê ®Æ ®w 
Link to:HAKKA TAIWANESE HAKKA CULURE  ¥x ÆW «È ®a ¤å ¤Æ ±M ¥Z  
Link to:TAIWANESE MEDICAL COMMUNITY   ¥x ÆW ¤H Âå ¾Ç ¬É ±M ¥Z 

¥xÆWªº²ü¾Ú®É¥N

¥vÀ³ª¾ ­ì¸ü¸t¸ô©ö¥xÆW¦P¶m·|¶m°T¤@¤E¤K¤K¦~¤G¤ë¸¹¡A ¤Î¤Ó¥­¬v®É³ø¤@¤E¤K¤K¦~¥|¤ë¥|¤é¡^

¥xÆW³QªiÄõ¦û¾Ú¤F¬ù¥|¤Q¦~¡A±q¤p¬F©²¤£Åý§Ú­ÌŪ¥xÆW¥v¡A¹ï²üÄõ¤H²Îªv¥xÆW³o¨Ç¦~ªº ±¡§Îª¾¹D¤£¦h¡C³Ìªñ¬Ý¤F´X¥»®Ñ¡A¬ù¬°¾ã²z¸`¿ý¦p¤U¡G ¥xÆW»P²üÄõÃö«Y¡A¦Û¤@¤»¹s¥|¦~°_¡A²ü±N­³³Â­¦¡]VAN WAERWIJCK¡^µn³°¼ê´ò°¨¤½¡A«á¨Ó ©ú±N¨H¦³®e­¢¥O¨äºM°h¡C¡]¤@¤E¤@¤E¦~¦b¼ê´ò°¨¤½¶ý¯ª¼q¤U±¸¥X¤@¥Û¸O¨è¦³¡u¨H¦³®e¿Ù °h¬õ¤òµf­³³Â­¦¡v¡C¡^²ü±N¹pº¸¥Í¡]REIJERSEN¡^¤@¤»¤G¤G¦~¤S¦û¼ê¦{¡A¨Ã«Ø«°¹ë¡C¤S ©ó¦P¦~²vÄ~©¹¥xÆW¦è«n®ü©¤½Õ¬d¡C¤@¤»¤G¥|¦~©ú§Ê¬£§L§ð¼ê¦{¥¼¦¨¡A©ú²üÁ¿©M½Í§P¡A²ü ©ñ±ó¼ê´ò¡A¦ý¥HÂà¶i¥xÆW¬°¨äºM°h¼ê´ò±ø¥ó¡C ²ü¤H¤@¤»¤G¥|¦~¥¿¦¡¦û¦³«n¥xÆW¡A²Îªv¥xÆW¤Ê¤K¦~¡C¦P´Á¶¡¤º¦è¯Z¤ú¦û»â¥_¥xÆW¡]¤@¤» ¤G¤»--¤@¤»¥|¤G¡^²Îªv¤µ°ò¶©¡B²H¤ô¥x¥_¡B©yÄõ¦U¦a¡C¤@¤»¥|¤G¦~²ü¤H»âÄ¥§ðÀ»°ò¶©¦è ¯Z¤ú­x¡A¦è­x¹è¤£¼Ä²³¡A§ë­°²ü¤H¤@¤»¥|¤G«á¤]²Îªv¥_¥xÆW¡A¤@¤»¤»¤@¦~¾G¦¨¥\²v¤j­x µn³°¥xÆW³ò§x²ü­x¤E­Ó¤ë¡A²ü¤H§ë­°¤@¤»¤»¤G¦~ºMÂ÷¥xÆW¡C ²ü¤H¤J«I¥xÆW«á¡A­n§â¥xÆWÅܦ¨²üÄõ´Þ¥Á¦a¡C¤@¤»¤T¤G¦~«ØZEELANDZIA«°¡A¤Î¬õ¤ò«°¡C ¤@¤»¤­O¦~«ØPROVINTIA«°¡A§Y¨ª®r¼Ó·í¨ä­x¨Æ»P¶T©ö¤§¿ì¤½¦a¡C¨ì«á¨Ó¦³¤»OO¦h¾­û¡C ¤GOOO¦h§L°¨¾n¥xÆW¡C·í®É¦b²ü¾Ú®É¥N´X­Ó­«­n¨Æ±¡¡G ¡]1¡^ ¥x«n·í®É¦a¦ì¬O¤@­Ó«D±`­«­nªºÂà¤f´ä¡A¤@¦p¤µ¤§­»´ä¡A¿é¥X³À¦×¡B³½°®¡B»È¡B ²¸ÁD¨ì¤¤°ê¡C¦Û¤¤°ê¿é¤Jµ·º÷¡A¯÷¥HÂà°e¼Ú¬w¡C³À¥Ö¿é¥X¨ì¤é¥»¡]¦h®É¤@¦~¤@¤­¡BOOO ±i¡^¬°ªZ¤h¸Ë¤§¥Î¡C¤S¬O«n¬v­»®ÆªºÂà¤f¯¸¡A©|¦³¦Ì»P¬â¿}¹B°e¦U¦a¡C²ü¤H¥¼¨ì¥xÆW «e¡A³o¨Ç¶T©ö¥Ñ¤¤°ê¤H©Î¤é¥»¤H¸gÀç¡C²ü¤H¤@¨Ó°¨¤W¦V¤¤¤é°Ó¤H½Òµ|¡A¤S¦³¨ä¥L¨Æ¥ó»P ¤é¤H¦³½Ä¬ð¡]¨£¤U¡^¡C¤é°Ó¦³¤é¥»¬F©²¼µ¸y¡Aº~¤H«hµL§U¡C ¡]2¡^ ¤é²ü½Ä¬ð¡G¤é°Ó³Q²ü½Òµ|·¥¤£º¡¡A¤é²üÃö«Y´c¤Æ¡A¥xÆW¤§²ü¤Hªø©x¦]¦Ó³QºM¡A§ï ¬£·sªø©x¨Ã¿Ë¨ì¤é¥»ªí©ú¨ú®ø¤é°Ó¤§½Òµ|¡C¤@¤»¤G¤C¦~ÀØ¥ÐÀ±§L½Ã²îªø¹ïªy©ó¦w¥­´ä®É ³Q¦©¨Ã¨S¦¬ªZ¾¹·¥¬°¤£º¡¡C¤@¤»¤G¤K¦~ÀإЦ^¤é¡A¤S²v²î°¦¨Ó¥x¡A­n¨D¦b¥x²ü¤HÁ¸o¤Î ½ßÀv¡A²ü¤HÄF¤éÄ¥¤J´ä¡A¨S¦¬ªZ¾¹¡A¦ýÀإжe¨ú²üªø©x¥H¬°¤H½è¡A²ü¤HµªÀ³¨ä½ßÀv±ø ¥ó¡A¦b¥x¤§º~¤H«o¤´»Ý¦b²ü¤H´Þ¥Á¤Î¤é¥»®üµs¤U¨D¥Í¦s¡C ¡]3¡^ ¹A·~¬Fµ¦¡G°£¤Ö¼Æªu®ü°Ï¥~¡A¨ä¥¦¦³«Ý©Ý¯î¡A²ü¤H±q¦L«×¿é¤J¯Ñ¤û¤S¿é¤J¤£¤ÖºØ ¤l¡A¤Î­]¤ì¥æ»Pº~¤H»P¡u¥­¦aµf¡v¨Ï¥Î¡C¤S±q¼sªF»PºÖ«ØÄF¤F¤j§åº~¤HÀ½¸Ë¦b¤j²î²î©³ ¹B©¹¥xÆW¡C³o¨Ç¦­´Á¨Ó¥x¯ª¥ý¥H¹A¥£¨­¥÷¥h­ì³¥¶}¾Á¡A³o¨Ç¨¯¨¯­W­W¶}¾Á¥Ð¶é²ÎÂk²üÄõ ©Ò¦³¡A§Y©Ò¿×¡u¤ý¥Ð¡v¡C²{¦b¥xÆW¦³ªº¤V¶q¨î«×¡u¥Ò¡v¦b¤j³°¥¼¦³¡A¾Ú¦ÒÃÒ¤´¬O²ü¤H¿ò ¯dªº¨î«×¡C ¡]4¡^ ­ì¦í¥Á¬Fµ¦¡G¹ï¥xÆW¤]¬I¦æ±Ð¨|»P¶Ç±Ð¡C¨äªª®v¶Ç±Ð¦h¦~¡A§ï«H°ò·þ±Ð¤§­ì¦í¥Á «Ü¦h¡C¥Îù°¨¦r¨Ó¼g­ì¦í¥Á¤§¤å¦r¡A¦b¥xÆW¬y¶Ç¤F³Ì¤Ö¦Ê¦~¥H¤W¡C¡]·s´ä¤å®Ñ¦Ê¦~«á­ì ¦í¥Á­q«´¬ù§Y¦³º~¤å»P­ì¦í¥Á¤§Ã¹°¨¤å¨Ã¥Î¡AÁÙ¦³­ì¦í¥Áù°¨¦r¤§±Ð¸q®Ñ¤Î¦r¨å¦s¦b ¡^¡C¹ï­ì¦í¥Á²Î±s¬Û·í¦¨¥\¡A²ü¤H±`¥i§Q¥Î­ì¦í¥Á¥´À»º~¤H¡]¥Hµf¨îº~²M´Âªu¥Î¡^¡A·í ²ü¤H±q¥xÆWºMÂ÷®É¦³³\¦h­ì¦í¥ÁÀH²î¦Ó¥h¡A¦ý¦³¨Ç³¡¸¨¹ï²ü¤H¤Ï§Ü¤´«D±`¿E¯P¡A²ü¤H¤] §Q¥Î¤£¦P³¡¸¨¨Ó¤¬¬Û²o¨î¡]¥Hµf¨îµf¡^¡C±q·í®É²ü¤H°O¸ü¡Aº~¤H»P­ì¦í¥Á¤k¤H³q±BªÌ¤£ ¤Ö¡A©ºªA­ì¦í¥Á¬Y¨Ç³¡¸¨®É¡A±N¨ä¤k¤H°tµ¹º~¤H¡]¹A¥£¡^¬°©d¡C ¡]5¡^ ³¢Ãh¤@¨Æ¥ó¡G¤@¤»¤­¤G¦~³¢Ãh¤@¬Ý¤£ºDº~¤H³Q²ü¤H­â°d¡A­p¹º¤Ï«q¡A¦ý³¢Ãh¤@¤§ §Ì·¥¤OÄUªý¨ä¥S¤£¦¨¡A·È¥X¥h¨ª®r¼Ó§i±K¡A²ü¤H¥B±o­ì¦í¥Á¤§§U¡A³¢Ãh¤@³Q±þ¡C§Ü²ü¨Æ ¥ó¤¤¦@¦³¤»¡BOOO¦h¨k¤H³Q±þ¡A¨Ã¦³°üÀ©¤­¤d¦h¤HÄ묹¡C¦P®É¦U¦a³¡¸¨¤@Å¥º~¤H¾Ô±Ñ¡A ªþªñº~¤H´X¥G³Q­ì¦í¥Á±þ¥ú¡C ¡]6¡^ ²ü¤H´Þ¥Á¬Fµ¦¡G°£¤F¤W­z¤ý¥Ð¨î¥~¡A²ü¤H¤]¬O¡u¦Êµ|¡v¨î¡A¦³¤HÀYµ|ª«µ|¡BÃö µ|¡B®·³À°õ·Óµ|º®·~µ|¡B²¸ÁD±Ä±¸µ|¡A¥xÆW¤H¨ü²ü¤H´Þ¥Á¦a¦¡ªº­é«d¡A©Ç¤£±o¦³¤j³W¼Ò §Ü¼É¨Æ¥ó¡C

¥x ÆW ±M ¥Z : 1)¥xÆW¾ú¥v¤Î¦å½tªº°Q½× 1¡^ ±q¸²µå¿}¤»ÁC»Ä¥h²B»Ã¯À(G6PD)¬Ý¥xÆW±Ú¸sªº¦å½t 2) ±q§K¬Ì²y³J¥Õ(Immunogloblulin)¬Ý¥xÆW±Ú¸sªº¦å½t 3) ¥xÆW±Ú¸sªº¦å½t 4) <ÄU©M½×>ªº°Q½× 5) ½Ö¬O¸q¥Á¤§«á¤H 6) ¥xÆWªº²ü¾Ú®É¥N 7) Glucose-6-Phoshate Dehydrogenase (G6PD) Mutants As Markers for Migration: Taiwan as an Example 8) Allotypes of Immunoglobulin as a Marker for Migration: Taiwan as an Example

±q§K¬Ì²y³J¥Õ¬Ý¥xÆW¤Hªº¦å½t

¦¶¯u¡Ð(St. Louis¤j¾ÇÂå¾Ç°|¤ÎCardinal Glennon¨àµ£Âå°|¤p¨à¬ì¦å²GÀù½F²Õ)

­ì¸ü<¥xÆWÂå¬É>¡]Taiwan Medical Journal) 44(9): 17-22. (September, 2001)

(¤@)«e¨¥ ¡@¡@«È®a¤H©ÎHolo(¦³ºÖ¦Ñ¡BºÖ¨Ð¡Bªe¨Ð¡Bªe¬¥¡BÅb¨Ðµ¥¤£¦Pº~¦r¼gªk¡A¥»¤å¥H ¤U¥ÎºÖ¦Ñ)¤H¡A¤£ºÞ¦b¥xÆW©ÎµØ«n¡A¤j¦h¼ÆªººÖ¦Ñ¤Î«È®a¤H³£¦Û»{¯ª¥ý¨Ó¦ÛµØ¥_ ªº¡u¤¤­ì¡v¡A¡uªe¬¥(¶Àªe¬¥¤ô)¡v¦a°Ï¡A¦]¾Ô¶Ã©ÎºØºØ­ì¦]´X«×«n¾E¨ì¹FµØ«n¡A ©Î¦AªF´ç¨ì¥xÆW¡C¤j³¡¤ÀªººÖ¦Ñ¤Î«È®a¤H³£¦Û»{¬°¬O¡uº~¤H¡v¡A¬O¥_¤è¡u¥¿²Î¡v ªº¡uº~¡v±Ú«n¾Eªº«á¥N¡C ¡@¡@«È®a¤H¤ÎºÖ¦Ñ¤H¦b¥t¤@¤è­±¡A¤]³Q¨ä¥L±Ú¸s¤×¨ä¬O¼sªF¤H»{©w¬°¡u«Dº~¤H¡v¡A ¬Æ¦Ü¦b¦­´Á¦a²z±Ð¬ì®Ñ¤¤´X¦¸±N«È®a¤HÃÕ¯º¬°¡u³¥ÆZ³¡¸¨¡v©Î¡u­]ÆZ§O¤ä¡v¡A ºÙ«È®a¤H¬°ÊD¡A¬Æ¦Ü¼g¥X¬°¡u_«È¡v(¥ªÃä¥[¤ü®Ç)®a¡C(¸Ô¨£°Ñ¦Ò¤åÄm[1]²Ä¤@³¹ ªº°Q½×)¡CHolo¤@µü¤]¦³¤H»{¬°¥»¦rÀ³¬°¡u¸èæy¡v¡C³o¨Ç±a¦³Ã~©Ê¦WºÙªº¦r²´´N ¼v®g«È®a¡BºÖ¦Ñ«Ü¥i¯à»P²{¦bµØ«nªº¤Ö¼Æ¥Á±Ú¦³¦å½t¤Î²W·½ªºÃö«Y¡C ¡@¡@¥t¤@¤è­±³Ìªñ¦³¤H¥X®Ñ¤Î¼g¤å³¹¤@¦A±j½Õ»¡«È®a¤H¬O¥»¬°¶ë¥~¥Á±Ú(©Î«ü¦I ¥£)«á¸Ç[2¡A3]¡A¹ï¦¹»¡¡A§@ªÌ»¡¡G¡uªQ¥»¨q¶¯®Õªø¥Î¤T¤Q¦~ªº®É¶¡¦¬¶°¦U¦a¤£ ¦Pªº¦å²G¡A¹ï¦U¥Á±Ú©M±Ú¸sªºDNA¼sªx©â¼Ë½Õ¬d¡Aµo²{¤é¥»¤H¡BÁú°ê¤H©M«È®a¤H ¬Ò±a¦³¬Û¦PªºDNA¡A³oµo²{¨¬¥iÃÒ©ú«È®a¥»Äݶë¥~¥Á±Ú ¡v[3]¡C ¡@¡@ªQ¥»¨q¶¯´¿¬O¤j¨ÁÂå¬ì¤j¾Ç®Õªø¡A¬OªkÂå¾Ç±M®a¡A¥h¬dªQ¥»ªº¬ã¨s½×¤å¡A¥L ¥D­n¬O¥Î§K¬Ì²y³J¥Õ(Immunoglobulin)ªº¦UºØ²§«¬Åé(allotypes)¨Ó¬ã¨s¦U±Ú¸sªº ¦å½t(¦å·½)[4¦³ºî¦X¦^ÅU°Q½×]¡A¨Ã«Dª½±µ¬ã¨sDNA¡C¥H«e¤£¤Ö¤H¥Î¦¹¨Ó¬ã¨s¤ñ¸û ±Ú¸sªº²§¦P¡CªQ¥»¦³¤£¤Ö¦³ÃöªF¨È¦U¦a¸sÅ骺½×¤å¡A¸ò¥»§ä¤£¨ì¦³«È®a¤Hªº¼Æ¾Ú¡A ¤]±q¥¼¬Ý¨ì¥L»¡¹L«È®a¤H»P¤é¥»¤H¤ÎÁú°ê¤H¦³¬Û¦PªºDNAªº°O¿ý¡C¥h«H¸Ó¤å¤Î®Ñ ªº§@ªÌ¡A¥L±H¨ÓªQ¥»¤W­zªº½×¤å[4]¡A¨º¤å®Ú¥»¨S¦³«È®a¤Hªº¼Æ¾Ú¤]¨S¤W­zªºµo²{¡A ·Q¬O§@ªÌ¦Û¤vªº±À·Q¡A¨ÃµL®Ú¾Ú¡C±q¦P¼Ë¬ã¨s§K¬Ì²y³J¥Õ»¯®ä­Zµ¥[5,6]µØ«n«È®a ¤Hªº¼Æ¾Ú¥H¤Î¨ä¥L¥H¤U°Q½×¨ì¦UºØ¥Íª«¾Çªº¬ã¨s¡A«È®a¤H¸ò¨ä¥LµØ«nº~¤H¥D­n·½ ¦Û«n¤è±Ú¸s¡A¤£¤Ó¥i¯à¬O¥_¤è¶ë¥~¥Á±Ú«á¸Çªº»¡ªk ¡C ¡@¡@±q´M§äªQ¥»ªº½×¤å¤¤¤]§ä¨ì¤£¤Ö¨ä¥L¤H¦¹¤è­±ªº¬ã¨s¸ê®Æ¡C¥Ø«eÁö¨S¤H¥Î §K¬Ì²y³J¥Õ¨Ó¬ã¨s±Ú¸s¦å½tÃö«Y¡A¦]¬°¤À¤l¥Íª«¾Ç§ó¶i¨B¦³§ó¦n¤èªk¡A¥iª½±µ ¬ã¨sDNA²§¦P¡A§ä±Ú¸s¦å½t(¦å·½)ªºÃö«Y¡C±q¦¬¶°¨ìªº§K¬Ì²y³J¥Õ²§«¬Åé¤åÄm¤¤ ¤´¦³¤£¤Ö¦³»ù­Èªº¸ê®Æ¡A¥i¤ÀªR¾ã²z¥X¨Ó±´°Q±q§K¬Ì²y³J¥Õªº¨¤«×¨Ó±´´ú¥xÆW ¤H±Ú¸sªº¦å½t¡C ¡@¡@¦¹¤å¥Î¦å¡u½t¡v¦Ó¤£¥Î¦å¡u·½¡v¡A¦]°Q½×¥D­n¬O±Ú¸s¶¡ªºÃö«Y¦Ó¤£´±½T©w ¨ä¦å²Îªº²W·½¡A¦ý¨â­Ó¦Wµü¤´¬O«ÜÃø¤À§O²M·¡¡C³o¸Ì­n¦A±j½Õ±Ú¸sºc¦¨¤Î¨ä¶¡ ªºÃö«Y¤£¥u¬O¦å²Î¤Wªº¿ò¶Ç°ò¦]¦Ó¤v¡C»y¨¥¡B¤å¤Æ¡B­·«U¡B²ßºD¡B¾ú¥vµ¥³£¬O «Ü­«­nªº¦]¯À¡A¦ý±q¥Íª«¾Ç¤W¨Ó±´°Q¦å½tÃö«Y¦Û¦³¨ä·N¸q ¡C ¾ú¥vªº°O¸ü¥i¯à¦³¤H¬°¤×¨ä¬O²ÎªvªÌªº¾ÞÁa¼vÅT¡A¨ä¥¿½T©Ê¦³¨Ç­È±oÃh ºÃ¡A¥Íª«¾Çªº¼Æ¾Ú¸û ¤Ö¤H¬°ªº¦]¯À¡A¦]¦Ó¦³¸û«ÈÆ[ªº¬Ýªk¥i¸ê°Ñ¦Ò¡CÄ´¦p¬ü°ê ³Ç¦ò´Ë(Thomas Jefferson)Á`²Î¨ì©³¦³¨S¦³¸ò¶Â¥£¤kºÞ®a¥Í¤U¤p«Ä¡A¥L¤Î¥L¥Õ¤H ªº«á¥N´¿¤@ª½§_»{¡A¦ý³Ìªñ§ä¶Â¥£¤Î¨ä¥L®a¤Hªº«á¥NªºDNA¥h¤ÀªR¡Aªº½T¥Íª«¾Ç ¤W¥iÃÒ©ú¥L³Ì¥i¯à¬O¶Â¥£¤p«Äªº¤÷¿Ë[7]¡A²{¦b³s³Ç¦ò´Ë¥Õ¤H¤k¨àªº«á¸Ç¤]±µ¨ü ³o¨Æ¹ê¡C ¡@¡@½Í¨ì¥xÆW¤H±Ú¸sªº¦å½tÃö«Y¤@¦V¬O±Ó·P¤Î¦³ª§Ä³ªº¸ÜÃD¡C§Ú­Ì³o¸Ì©ÒºÙªº ¡u¥xÆW¤H¡v¬O«ü²{©~¦í©ó¥xÆWªº¦U±Ú¸s¡A¥]¬A¦³­ì¦í¥Á¡BºÖ¦Ñ(»Ô«n)¡B«È®a¤Î·s ¦í¥Á(¥~¬Ù¤H¡B¤j³°¤H)¡C¤j®a©ÒºÙªº¡uº~¤H¡v¡A±q¥Íª«¾Ç¬Ý¨Ó¬O¸ûÅ¢²Î¼Ò½kªººÙ ©I¡A«ÜÃø¤U©w¸q¡C¥H¤U·|°Q½×±q¦UºØ¬ã¨s³£«ü¥X©ÒºÙªºº~¤H¦³«n¥_¤£¦Pªº°_·½¡A ¦U¦aº~¤H¦å²Î§ó¬O²VÂø¡A¸Ó¬O¤å¤Æ©Î¬Fªvªº±Ú¸s¦WºÙ¡A¦ý¥Ø«e«Ü¤j³¡¤Àªº¤HÃþ¾Ç ªº¬ã¨s½Õ¬d¤Î¥»¤å©Ò¤Þ¥Îªº¤åÄm¤´¥Îº~¤Hªº¦WºÙ¡A©Ò¥H·Ó­ì¤åÄm¨Ï¥Îº~¤H¤@µü¡C ¡@¡@¦¹¤å¦b¤U°Q½×¤ÀªR®É·|¤@¦A´£¨ì«È®a¤H¤ÎºÖ¦Ñ¤H¥»¥D­n¬O·½¦ÛµØ«nªº±Ú¸s(§Y ©Ò¿×ªº¡u«nÆZ¡v)¡A¦Ó¸û¤Ö·½¦Û¥_¤èªº¡u¤¤­ì¡v©Î¡uªe¬¥¡vªº±Ú¸s¡C¤£¤Ö¥xÆWªº ­ì¦í¥Á(©Ò¿×ªº¡uµf¡v)ªº°ò¦]¤]¿Ä¤J¤F¥xÆWªººÖ¦Ñ¤Î«È®a¤H¤¤¡C³o¨Çµ²½×¥i¯à·| ¤Þ°_¤£¤Ö¤H¼««ã©Î¤£¥­¡A¦]¬°¥D­n¬O¡uÆZ¡v¤Î¤£¤Ö¡uµf¡vªº¦å½t¡C¦b¦¹¯S§O­n¦A ±j½Õ±Ú¸s¥»µL¶Q½â¡B°ª§C¡BÀu¦H¤§§O¡A³o¸Ì©Ò°Q½×±Ú¸sÃö«Y¤Î²W·½¬O±q¥Íª«¾Ç¤W ªºÆ[ÂI¨Ó¬Ý¡A­Y¬O¥D­n·½¦Û¡u«nÆZ¡v¨Ã¦³¡u¥Íµf¡v¦å²Î¡A¨Ã¤£¥i®¢¡A§ó«D­I¯ª©Î ¦Ã½°¥xÆW¤H¡C¥u¬O·Q±q¥Íª«¾Ç¤W¨Ó±´°Q¡A¤£¦ý¦³§ó«ÈÆ[ªºÁA¸Ñ¡A¤]·|¹ïÂå¾Ç°·±d ¤Î«O°·¦³©Ò§U¯q¡AÄ´¦p¥i¤F¸Ñ¬°¦ó¸²µå¿}¤»ÁC»Ä¥h²B»Ã¯À¯Ê¥F¯g¡]©Ò¿×ªºÅú¨§¯g¡^ ¤Î¦a¤¤®ü³h¦å¸û¦h¦Ó§ó¥hª`·N¡A¨Ã¹ï¦ó³B¥h´M§ä°©Åè©Î¾¹©x²¾´Ó®½¿éªÌ¤]¦³À°§U¡C (¤G)§K¬Ì²y³J¥Õ²§«¬Åé¤Î±Ú¸s¦å½t ¡@¡@§K¬Ì²y³J¥Õ¦³¤­ºØ¡A§YG¡BA¡BM¡BD¡BE¡A´¶³q¥ÎIgG¡BIgA¡BIgM¡BIgD¡BIgE² ºÙ¡C¨CºØ³£¦³­«³J ¥ÕÃì¤Î»´³J¥ÕÃì (Heavy & light chains)¡C¦UºØ¤S³£¦³¤£¦Pªº ­«Ãì¡A¤À§O¥H£^¡B£\¡B£g¡B£_¡B£`ºÙ©I ¡C¦Ó ¥B³£¦³£e¤Î£f¨âºØ»´Ãì¡C³o¨Ç»´­« ³J¥ÕÃì¥Ñ¤£¦Pªº®ò°ò»Ä (amino acid) ²Õ¦¨¡AIgG¤ÎIgA¤S¥i¦A²Ó¤À¦¨IgG1¡BIgG2¡B IgG3¡BIgG4¤ÎIgA1¡BIgA2¡C ¡@¡@¦U³J¥ÕÃ즳«í©w(constant)¤ÎÅܲ§(variable)¨â³¡¤À¡AÅܲ§ªº³¡¤À´N¬O¨M©w§K ¬Ì²y³J¥Õªº¯S®í©Êªº³¡¤À¡A¦Ó«í©w³¡¤À¦]¦³¤@­Ó©Î¨â­Ó®ò°ò»Äªº¤£¦P¦Ó¦³²§«¬Åé¡A ·íµM®ò°ò»Äªº¤£¦P¬ODNAªº®Ö»Ä°ò(Nucleotide)ªº¬ðÅܦӨӡC³o¨Ç¤£¦P²§«¬Åé¦b¤£ ¦Pªº±Ú¸s¦³¤£¦PªºÀW²v¡A©Ò¥H±`¥i¥Î¨Ó¬ã¨s¦å½tªºÃö «Y¡C ¡@¡@IgG1¡BIgG2¡BIgG3¡BIgA2¡BIgE¦@¦³21ºØ²§«¬Åé[8]¡A³o¨Ç²§«¬Å骺Á`ºÙ¤À§O ¥HG1m¡BG2m¡BG3m¡B A2m¡BEmºÙ©I¡A¦Ó²§«¬Å骺¦WºÙ«h¥Ñ¥@¬É½Ã¥Í²Õ´(WHO)¶}·|¨M ©w©R¦W¡A¥Ø«e¦³¨âºØ©R¦W¤è¦¡¡A¥Î¼Æ¥Ø ©Î¦r¥À¥[¼Æ¥Ø©R¦W(ªí¤@)¡C ªí¤@ §K¬Ì²y³J¥Õªº²§«¬Åé ________________________________________________________________________ Light Chains Heavy Chains ________________________________________________________ £^1 £^2 £^3 £\2 £` Km G1m G2m G3m A2m Em ________________________________________________________________________ 1 a,f n g1(g),g5,b0,b1,b3, 1 1 2 x,z b4b5,s,t,c3,c5,u,v 2 3_______________________________________________________________________ Numerical nomenclature for G1m:1=a,2=x,3=f,17=z; G2m: 23=n; G3m: 5=b1,6=c3, 10=b5,11=b0,13=b3,14=b4,15=s,16=t,21=g1(org),24=c5,26=u,27=v,28=g5 ¦ÛDe Lange GG [8]²¤¥[­×§ï ¡@¡@G1m¦³¥|ºØ²§«¬Åé¤À§O¬°G1m(a),G1m(x),G1m(f)¤ÎG1m(z)©R¦W¡A©Î¤]¥i¼g¦¨G1m(1)¡B G1m(2)¡BG1m(3)¡BG1m(17)¡C¨ä¤¤G1m(f)¤ÎG1m(z)©ÎºÙG1m(3)¤ÎG1m(17)¤£¥i¯à¦b¦P¤@¤H ¨­¤Wµo¥Í¡A¦]¬°¨âªÌ¦b£^1­«Ãì¦P¤@®ò°ò»Ä(²Ä214)¤W¦³©Ò¤£¦P¡AG1m(f)¬OArginine ¦ÓG1m(z)¬OLysine¡CG3m¦³13ºØ¤£¦Pªº²§«¬Åé¡A¤À§O¬Ob1¡Bc3¡Bb5¡Bb0¡Bb3¡Bb4¡Bs¡B t¡Bg1(©Î¥uºÙg)¡Bc5¡Bu¡Bv¡Bg5©Î¥H¼Æ¥Ø5¡B6¡B10¡B11¡B13¡B14¡B15¡B16¡B21¡B 24¡B26¡B27¡B28)©R¦W[8]¡CG2m¡BIgE¡BIgA¡B»´³J¥ÕÃì£e³£¥u¦³«Ü¤Öªº²§«¬Åé¡A ¹ï±Ú¸s¬ã¨s»ù­È¤£°ª¡C©Ò¥H¥»¤å¥u°Q½×G1m¤ÎG3mªº¬ã¨s¦¨ªG¡C³o¤GºØ­«Ã쪺²§«¬ Åé¦h¡A·|¦³«Ü¦h¤£¦Pªº²Õ¦X¡A¥Õ¤H¡B¶Â¤H¤ÎªF¤è¤H¦U¦³¬Û·í¤£¦Pªº²§«¬Åé²Õ¦X¤Î ÀW²v[8]¡C¦bªF¤è¤H¤¤³Ì±`¨£ªº¦³¥|ºØ²Õ¦X¡A¨C¬ã ¨s¸ÕÅç¤èªk²¤¤£¦P¦Ó¦³¤£¦Pªº ¼gªk¦pªí¤G¡C ¡@¡@³o¨Ç§K¬Ì²y³J¥Õªº²§«¬Åé¤@¯ëªº¬ã¨sªÌ³£¬O¥Î¬õ¦å²y¾®¶°§í¨îªk (Hemaggluti- nation Inhibition)¨Ó¸ÕÅç¡A¦ý¨C­Ó¹êÅç«Çªº¤èªk²¤¦³¤£¦P¡A¥Îªº¦å²M¤]¤£§¹¥þ¬Û ¦P¡A¤@¯ëªº³ø§i³£¬O¥Î¦¹ªk§ä¥X¦U¸sÅé²§«¬Å骺ªí²{«¬(phenotype)µM«á¦A­pºâ¥X¬V ¦âÅ髬(haplotype)ªº°ò¦]ÀW²v¨Ó¤ñ¸û²§¦P ¡C ¡@¡@§Q¥Î³oºØ¤èªkºâ¥XÀW²v²§¦P¨Ó¬ã¨s±Ú¸s¦å½tÃö«Yªº¤å³¹¤£¤Ö¡C¹ïªF¤è¤H¡]»X ¥j±Ú¡^ªº¬ã¨s´N¦³¦n´X²Õ¬ã¨s¤H­û±q¨Æ¦¹¬ã¨s¡C¹ï¥xÆW¤Hªº¬ã¨s³£¬O¥~°ê¤H¨Ó¥x ÆW¦¬¶°¦å²G¡A¦A°e¦^¬ü°ê¤Î¤é¥»¹êÅç«Ç¤ÀªR¡C¦]¦­¦~¤¤°ê«Ê³¬¡A¤£©ö¥h¤¤°ê¤j³° ±Ä¶°¦å²G¼Ë¥»¡A¦³¨Ç¤¤°ê¤Hªº¬ã¨s¸ê®Æ¬O¥H¥X¥Í©ó¤¤°ê¦Ó¦b¥xÆWªº·s¦í¥Á¡]¾Ô«á ¨Ó¥x¡A©Ò¿×¥~¬Ù¤H¡B¤j³°¤H¡^ªº¦å²G¬°¹ï¶H¡C¤W®ü¿é¦å¬ã¨s©Ò«h¬O¦Û¤v°µªº¬ã¨s¡C (¤T)¤èªk ¡@¡@¥ý¦b¹q¸£ºô¸ô¤åÄm¸ê®Æ®wªºMedline¤ÎBiologicalAbstract§ä¨ìMatsumoto©Ò ¦³¬ã¨s½×¤åªº²M³æ¡A§ä¥X¦³Ãö¥xÆW¥H¤Î¤¤°ê¤Î¨ä¥L¤@¨Ç¦³Ãö¦a¤èªº¬ã¨s¤å³¹¡A¦P ¼Ë¦a¦bMedline¤ÎBiologicalAbstractªº¯Á¤Þ¤¤¥i¦A§ä¨ì¨ä¥L§@ªÌ¦³Ãöªº³ø§i¡C ­Y¦¹¦a¹Ï®ÑÀ]§ä¤£¨ìµn³o¨Ç½×¤åªºÂø»x¡A«h¥Ñ¤j¾Ç¹Ï®ÑÀ]¤ÎÂå°|¹Ï®Ñ«Çªº¯²­É¤Î ´M§ä¸ê®Æ¿ì¤½«Ç¥h­n¨ì­ì³ø§iªº¼v¦L¥»¡Cµoªí©ó¤¤°êªº¤¤¤å½×¤å¤]¤£Ãø¦¬¶°¨ì¡C ¡@¡@¤¤°ê»¯®ä­Zµ¥[5,6]¥H¤Î¤é¥»Matsumoto[4]ªº¸ê®Æ¼Æ¾Ú«Ü¦h¡A¤£¯à¤@¤@Âà¸ü¡C ¥»¤å­º¥ý¥u¦C¥X¦³¥xÆW¤H±Ú¸s¼Æ¾Úªº³ø§i(ªí¤T)¤Î¤ñ¸û¨â³ø§i¤¤¦³¦P¤@¦a°Ï¬ã¨s ½Õ¬dµ²ªGªº¼Æ¾Ú(ªí¥|)¡CµM«á¨Ì¾Ú¦a¹Ï[15]¡A°£±¼¥H¤U·|´£¤Î¦³©úÅãµ{«×¤£¦P¦³ ¥Õ¤H¦å²Îªº¦U±Ú¤Î¦è«n³¡ÂäHªº¸sÅé¥~¡A¥H½n«×¨C¤­«×¬°¤@¦a±a¡A±N»¯®ä­Zµ¥¤Î Matsumoto¦U¸sÅ骺¼Æ¾Ú¤À§O¥­§¡°_¨Ó¦Cªí¦bªí¤­¡Cªí¤»¬O¥t¤@²Õ¥D­n¬ã¨s¥xÆW ·s ¦í¥Á ¦b¤£¦P¤¤°ê ¦a°Ï¥X¥ÍªÌªº¥­§¡¼Æ¾Ú¡C ªí¤G: ¤£¦P¬ã¨sªÌ¹ï¦PG-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦Xªº¤£¦P¼gªk ___________________________________________________________________________________ Matsumoto* DeLange et al^ Schanfield et al# Zhao et al** Tran et al^^ ____________________________________________________________________________________ Gm(ag) Gm(zag) Gm(ag) Gm(1,21) Gm(1,17,21) Gm(ab3st) Gm(zab0b3b5st) Gm(abst) Gm(1) Gm(1,17,10,11,13,15) Gm(axg) Gm(zaxg) Gm(axg) Gm(1,2,21) Gm(1,2,17,21) Gm(afb1b3) Gm(afb) Gm(afb) Gm(1,3,5) Gm(1,2,5,10,11,13,14) ____________________________________________________________________________________ * ±q¤åÄm[ 4], ^ [9], # [10], ** [ 5,6] , ^^ [11] ªí ¤T ¥xÆW¤HG-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XªºÀW²v ________________________________________________________________________ Groups Gm(ag)1,21 Gm(ab3st)1 Gm(axg)1,2,21 Gm(afb1b3)1,3,5 By Nakajima/Ohkura#{Gm1# --- Gm1,2# Gm1,5#} Ami 0.055 --- 0.007 0.938 Atyal 0.159 --- 0.008 0.834 Bunun 0.081 --- 0.034 0.885 Paiwan 0.199 --- 0.101 0.701 “ Han” 0.221 --- 0.057 0.722 By Matsumoto* Atyal 0.155 0.000 0.023 0.821 Bunun 0.226 0.000 0.034 0.740 Paiwan 0.207 0.002 0.042 0.762 “ Han” 0.222 0.047 0.087 0.643 By Schanfield^ “ Han” 0.220 0.046 0.086 0.649 __________________________________________________________________ # Nakajima & Ohkura [12]; * Matsumoto H etal [13,14]; ^Schanfield MS et al [10] ªí¥|: ¦P¦a°Ï¤£¦P½Õ¬dG-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XªºÀW²v _______________________________________________________________________ Groups Gm1,21(ag) Gm1(ab3st) Gm1,2,21(axg) Gm1,3,5(afb1b3) «¢º¸»« 0.441*/0.421^ 0.113/0.139 0.210/0.211 0.236/0.229 ªø¬K 0.471/0.405 0.089/0.120 0.219/0.203 0.221/0.280 ¤j³s 0.384/0.370 0.094/0.128 0.266/0.210 0.256/0.292 ¦è¦w 0.405/0.381 0.113/0.161 0.183/0.180 0.299/0.278 ¦XªÎ 0.416/0.356 0.084/0.116 0.172/0.169 0.328/0.380 ªZº~ 0.290/0.182 0.055/0.202 0.131/0.116 0.524/0.500 0.289 # 0.078 0.131 0.502 ºÖ¦{ 0.188/0.184 0.043/0.139 0.077/0.083 0.692/0.595 ªø¨F 0.204/0.216 0.054/0.118 0.066/0.058 0.676/0.608 ¦¨³£ 0.168/0.168 0.048/0.145 0.078/0.066 0.706/0.621 ¶Q¶§ 0.226/0.178 0.043/0.177 0.085/0.054 0.646/0.591 ¼s¦{ 0.183/0.096 0.033/0.124 0.054/0.039 0.730/0.741 _______________________________________________________________________ * From Matsumoto H[4] / ^ Zhao TM et al [5,6]; # DeLange GG et al [9] ªí¤­: ¤¤°ê¤H¦U¸sÅé«ö·Ó½n«×ªºG-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XÀW²v ________________________________________________________________________________________ Groups Gm1,21(ag) Gm1(ab3st) Gm1,2,21(axg) Gm1,3,5(afb1b3) »¯®ä­Zµ¥ªº¸ê®Æ¤¤¤Ö¼Æ¥Á±Ú¤Îº~ ¤H[±q°Ñ¦Ò¤åÄm5,6] ¥_½n 45o ¥H¥_ (3) 0.449 0.225 0.169 0.156 ¥_½n 40-45 o (8) 0.450 0.148 0.157 0.228 ¥_½n 35-40 o (10) 0.394 0.155 0.203 0.248 ¥_½n 30-35 o (18) 0.310 0.148 0.154 0.388 ¥_½n 25-30 o (20) 0.174 0.112 0.087 0.628 ¥_½n 25 o ¥H«n (8) 0.107 0.143 0.046 0.704 »¯®ä­Zµ¥ªº¸ê®Æ¤¤­­º~¤H¦Ó¤w[±q°Ñ¦Ò¤åÄm5,6] ¥_½n 40 o ¥H¥_ (2) 0.413 0.126 0.207 0.255 ¥_½n 35-40 o (7) 0.394 0.158 0.202 0.247 ¥_½n 30-35 o (17) 0.313 0.148 0.156 0.382 ¥_½n 25-30 o (13) 0.208 0.131 0.106 0.555 ¥_½n 25o ¥H«n (5) 0.148 0.123 0.056 0.673 ªQ¥»ªº¸ê®Æ[±q°Ñ¦Ò¤åÄm4] ªF¥_¤Ö¼Æ¥Á±Ú (3) 0.419 0.309 0.147 0.125 ¥_½n >40 o, º~¤H (3) 0.459 0.095 0.222 0.224 ¥_½n 35-40 o, º~¤H (3) 0.414 0.109 0.223 0.253 ¥_½n 30-35 o, º~¤H (6) 0.334 0.080 0.148 0.438 ¥_½n <30 o, º~¤H (4) 0.200 0.043 0.071 0.686 µØ«n¤Ö¼Æ¥Á±Ú (4) 0.053 0.018 0.009 0.921 ______________________________________________________________________________________ ¬A¸¹¤º¬O¤å¤¤¦U½n«×±a¤ºªº¸sÅ鼯¥Ø¡A¦U½n«×±a¤ºªºÀW²v¬O³o¨Ç¸sÅ骺¥­§¡ ªí¤»: ½Õ¬d¥xÆW ­ì¤¤°ê¥X¥Í©~¥ÁªºG-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XªºÀW²v _________________________________________________________________________________ Groups* Gm1,21(ag) Gm1(ab3st) Gm1,2,21(axg) Gm1,3,5(afb1b3) North 0.550 0.120 0.100 0.356 Central 0.329 0.067 0.180 0.423 South-Central 0.250 0.080 0.110 0.550 South 0.117 0.040 0.040 0.803 __________________________________________________________________________________ From Shanfield MS et al [reference 10] * South includes Kuantung, Kuangsi and Yunan; South-Central includes Chekiang, Chiangsi, Fukien and Hunan; Central includes Anhui, Chiangsu, Honan, Hupei, and Suchuan; North incudes Hopei, Shansi, Shantung, Shensi and Liaoning¡]¨Ì­ì¤å«÷­µ¡^ ¡@¡@ªí¤C¬O±N»¯®ä­Zµ¥[5,6]¸sÅ餤¡A±N¡u¤¤­ì¡v©Î¡uªe¬¥¡vªº¦a°Ï(¥Û®a²ø¡B¤Ó­ì¡B ¬¥¶§¡B¦è¦w¡B¦w¶§¡B°ªªô)¤ÎµØ«nªº¤Ö¼Æ¥Á±Ú(ÂU¡B­]¡B¥¬¥ì¡B¤ô¡BÚ®¡B»ò¨Ð¡B§§¡B ˾¡B¨Ê)¦UºØ²§«¬Åé¤ÎÀW²v¦C¥X¤Î¨ä¥­§¡¡Cªí¤K¦C¥XMatsumotoªº¼Æ¾Ú[4]¤¤¡u¤¤­ì¡v ¦a°Ïªº¦è¦w¤Î¥_¨Ê¤ÎµØ«n¤Ö¼Æ¥Á±Úªº­]¡B¥¬¨Ì¡B¤ô¤Î§§±Ú¡Cªí¤C¡B¤Kªº¼Æ¾Ú¦b°Q ½×¤¤·|»¡©ú¬O¥Î¨Ó­pºâªí¤EµØ«n¤Î¥xÆWªºº~¤H¥i¯à¦³¦h¤ÖµØ«n¤Ö¼Æ¥Á±Ú¡B¡u¤¤­ì ¤H¡v¤Î¥xÆW­ì¦í¥Áªº¡u¦¨¤À¡v¡C¹Ï¤@¬O±N»¯®ä­Zµ¥­ì¤å[5,6]®Ú¾ÚNei¤ó¤½¦¡ªk±NGm ²§«¬Åé²Õ¦XÀW²v¨Ó­pºâ¿ò¶Ç¶ZÂ÷©Òøªº¨t²Î¾ð¡A¦¹¹Ï¦C¥XµØ¤¤µØ«n32­Ó¸sÅ骺³¡ ¥÷¡A¨Ã¦b­ì¹Ï¥[¤W¸sÅé¦W¥N´À­ì¤åªº¸sÅé¥N¸¹¡A¸û©ö²M·¡¤F¸Ñ¦U¸sÅé¦å½tÃö«Y¡C ªí¤C: µØ«n¤Ö¼Æ¥Á±Ú¡BµØ«n º~¤H¤Î¡u¤¤­ì¤H¡vªºG§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XªºÀW²v ________________________________________________________________________________ Groups Gm1,21(ag) Gm1(ab3st) Gm1,2,21(axg) Gm1,3,5(afb1b3) ¡u¤¤­ì¤H¡v 0.382 0.172 0.188 0.257 ¥Û®a²ø 0.438 0.175 0.149 0.239 ¤Ó­ì 0.426 0.148 0.170 0.256 ¬¥¶§ 0.394 0.136 0.188 0.283 ¦è¦w 0.381 0.161 0.180 0.278 ¦w¶§ 0.300 0.223 0.230 0.248 °Óªô 0.355 0.189 0.216 0.240 µØ«n¤Ö¼Æ¥Á±Ú 0.074 0.097 0.030 0.788 ÂU 0.198 0.092 0.080 0.630 ­] 0.091 0.007 0.027 0.875 ¥¬¨Ì 0.061 0.084 0.017 0.838 ¤ô 0.039 0.035 0.004 0.921 Ú® 0.111 0.088 0.047 0.754 »ò¨Ð 0.022 0.178 0.033 0.767 §§ 0.036 0.192 0.000 0.772 ˾ 0.046 0.139 0.005 0.811 ¨Ê 0.062 0.060 0.057 0.725 µØ«nº~¤H ºÖ¦{ 0.184 0.139 0.083 0.595 ·Hªù¡] ºÖ¦Ñ ¤H¡^0.211 0.085 0.058 0.646 ±ö¿¤¡]«È®a¤H¡^ 0.118 0.138 0.027 0.717 ¼s¦{¡]¼sªF¤H¡^ 0.096 0.124 0.039 0.741 ______________________________________________________________________________ From Zhao TM et al [references 5,6] ªí¤K: Matsumoto½Õ¬d¤¤°êº~¤H¡B µØ«n¤Ö¼Æ¥Á±Ú¡B¤Î¥xÆWº~¤H¡B­ì¦í¥Áªº G-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XªºÀW²v __________________________________________________________________________________ Groups Gm(ag) Gm(ab3st) Gm(axg) Gm(afb1b3) µØ¥_¡u¤¤­ì¤H¡v 0.417 0.115 0.199 0.270 ¦è¦w 0.405 0.113 0.183 0.299 ¥_¨Ê 0.428 0.117 0.214 0.241 µØ«n¤Ö¼Æ¥Á±Ú 0.053 0.018 0.009 0.921 Miao(­]) 0.095 0.015 0.015 0.875 Puyi(¥¬¨Ì) 0.061 0.014 0.010 0.914 Shui(¤ô) 0.039 0.019 0.005 0.952 Chuang(§§) 0.036 0.022 0.005 0.942 µØ«nº~¤H 0.186 0.038 0.066 0.711 ºÖ¦{ 0.183 0.043 0.077 0.692 ¼s¦{ 0.188 0.033 0.054 0.730 ¥xÆW º~¤H 0.222 0.087 0.047 0.643 ­ì¦í¥Á 0.194 0.042 0.002 0.762 __________________________________________________________________________________ From Matsumoto H [reference 4] (¥|)µ²ªG¤Î°Q½× ¡@¡@ªF¤è¤H¡]»X¥j±Ú¡^ªºGm¥D­n¦³¥|ºØ²§«¬Åé²Õ¦X¡A¨C¬ã¨s²Õ©Ò´ú©w²§«¬Å鼯¥Ø ¤£¤@¡A·íµM·|¦³¨Ç¤£¦Pªºµ²ªG¡C¦­´ÁªºNakajima¤ÎOhkura¥u¦C¥X¤TºØ²Õ¦Xªº°ò¦] ÀW²v(ªí¤T)¡CªF¤è¤H°£¤F³o¥|²Õ¥~¡A¨ä¥L³£¬O·¥¨u¨£ªº²Õ¦X¡A¥þ³¡·¥¨u¨£ªº²Õ¦X ¥[°_¨Ó³£¤£¶W¹L0.5¢H¡C¨ä¥LºØ±Ú¦p¥Õ¤H¤Î¶Â¤H«h¥t¦³¨ä¥LºØ²Õ¦X[8]¡C ¡@¡@¥Ñ©ó¨C¤@¬ã¨s«Ç¥Î¤£¦P¼Æ¥Øªº§ÜÅé¦å²M¡A©Ò¦³¦å²M¤S¬O¤£¦P¨Ó·½¡A¨ä¥L©Ò´ú ©wªº²§«¬Å餣¤Ó¬Û¦P¡A°£¤F¤¤°ê»¯®ä­Zµ¥[5,6]¨º²Õ¥~¡A¨ä¥Lªº¬ã¨s³ø§i¦b¦P¤@¦a °Ï³£¦³·¥¬Û¦üªºµ²ªG¡A¦pªí¥|ªZº~¦a°Ï Matsumoto [4]¤ÎDeLange et al[9]ªºµ²ªG ¡A ªí¤T¥xÆWº~¤HMatsumoto[4]¤ÎShanfield et al[10]ªºµ²ªG ³£·¥Ãþ¦ü©Î´X¥G¤@¼Ë¡C ±N»¯®ä­Zµ¥[5,6]ªºµ²ªG¸ò¨ä¥L¬ã¨s²Õ¤ñ¸û·|µo²{¡A¥L­ÌªºGm1(¬J¨ä¥L¬ã ¨sºÙªºGmab3st)ªº²§ «¬Åé²Õ¦XÀW ²v¡A¤×¨ä¦bµØ«n¦a°Ï³£¸ûMatsumoto[4]¤ÎDelange et al[9]°ª±o¦h¡A³o¥i¯à¬O¥Ñ©ó»¯®ä­Zµ¥¦¹²Õ¦X¥u¥Î¤@ºØªº¦å²M¡A­Y¨ä¥L²Õ¦Xªº §ÜÅé¤ÏÀ³¸û®z¡A¥i¯à³Ì«á³£·|Âk¨ì¦¹²Õ¦X¤¤¡C»¯®ä­Zµ¥ªº¼Æ¾Ú¤£¯à¸ò¨ä¥L¤H²V¦X ¤ñ¸û¡C¦ý¥L­Ì¦³¤H¼Æ³Ì¦h¡B¸sÅé³Ì¼sªº¼Æ¾Ú¡A¥i¤ÀªR´£¨Ñ¦³»ù­Èªº°Q½×¡C¶¶«K¤@ ´£¡AÁö¤£¦b¦¹°Q½×¡Aºû§^º¸¡B«¢ÂħJ¡BªF¶m±Ú¤Î¤@¨Ç¦^¤H¦³©úÅãµ{«×¤£¦Pªº¥Õ¤H ªº¦å·½¡A¥L­Ì¦³Gm3,5©ÎºÙGm(fb)ªº²§«¬Åé[5,6]¡C ¡@¡@ªí¤T¥i¬Ý¥X¥xÆWªºº~¤H»P­ì¦í¥Á¦³¨Ç®t§O¡A­ì¦í¥Á¤§¶¡¤]¦³¨Ç¤£¦P¡A¥xÆW ­ì¦í¥Á¸òµØ«nªº¤Ö¼Æ¥Á±Ú¶¡¤]¦³¬Û·íªº®t§O(ªí¤K)¡A¦Ó¥xÆWº~¤H¸òµØ«nªºº~¤H¤] ¬Û·í¤£¦P(ªí¤K)¡C±q¹Ï¤@¥i¬Ý¥X±ö¿¤«È®a¤H¡A¦å½t¤W³Ì¿Ëªñªº¬O¼s¦{ªºº~¤H¡A¨ä ¦¸¦b®ý¦¿´º¹çªºÚ®¤H¡A¦A¦¸¬O¬h¦{ªºº~¤H¡A¦A¦¸¬O»ò¨Ð¡B§§±Ú¡B˾±Ú¤Î¨Ê±Ú¡A µM«á¬O­]¤H¡B¥¬¨Ì¤Î¤ô±Ú¡C±ö¿¤¤Ï¸òµy»·¨Çªºº~¤H¦p¦b·Hªù¡Bªø¨F¡B¶Q¶§¡BºÖ¦{ µ¥µ¥¸û²¨»·¡C¦A¦p·Hªù¦a°ÏªººÖ¦Ñ¤H¸ò¦è©÷ÂU¤H¤Î»à¶§º~¤H³Ì¿Ë¡A¨ä¦¸¦A¬Oªþªñ ¦a°Ï¡A¦pªø¨F¡B¶Q¶§¡B¦ÂÀY¡B©y¬K¡BºÖ¦{¡B¦¨³£¤Î­«¼yªºº~¤H ¡C ¡@¡@©Ò¦³ªº¬ã¨s¤£ºÞ¬O¤¤°êªº»¯®ä­Zµ¥[5,6]¡B¬ü°ê ªºSchanfield et al[10]©Î¤é ¥»ªºMatsumoto[4]³£¦³¤@¼Ëªºµ²½×¡AªF¤è¤H(»X¥j±Ú¡B¶ÀºØ¤H)«Ü©úÅã¦a¤À¬°«n¥_ ¨â¤jÃþ«¬¡A«n¨È¤j±Ú¸s¦³°ªÀW²vªºGm1, 3, 5©ÎºÙGm(afb1b3)¡A¥_¨È¤j±Ú¸s«h¦³°ª ÀW²vªºGm1,21©ÎºÙGm(ag)¡C¤¤°ê¤H¤]¤@¼Ë¦³«n¡B¥_¨â­Ó¤£¦P°_·½ ªºµ²½×¡C ¡@¡@³oºØ°²»¡¥i¦A¥Îªí¤­¡Bªí¤»¨Ó¦õÃÒ¡Aªí¤­¥Ñ¥i¬Ý¥X¬Oº~¤H»P§_¡A¨ÃµL¬Æºò ­n¡A·U«nªºGm1,3,5ÀW²v·U°ª¡B·U¥_ªºGm1,21·U°ª¡CµØ«nº~¤H¸òµØ«nªº¤Ö¼Æ¥Á±Ú¦³ ¸û¬Ûªñªº¦å½tÃö«Y¡AµØ«nº~¤H¥i¯à¥D­n¬OµØ«n¡u­ì¦í¥Á¡v±Ú¥[¤W¸û¤Ö¦¨¤ÀªºµØ¥_ ¡u¤¤­ì¤H(ªe¬¥¤H)¡vªº«á¸Ç¡C¥Ø«eµØ«nªº¤Ö¼Æ¥Á±ÚÀ³¬O¥¼º~¤Æªº¡u­ì¦í¥Á¡v¡A­Y ¦A°²©w¥Ø«eµØ¥_ªº¡u¤¤­ì¤H¡v¸ò±q«e«n¾E«eªº¡u¤¤­ì¤H¡v¦³¦P¼ËªºÀW²v¡A§Ú­Ì¥i ¥H¥Î²³æ¼Æ¾Ç±Àºâ¥XµØ«nªºº~¤H¦³¦h¤ÖµØ«n¡u­ì¦í¥Á¡vªº¦¨¤À¡A¤Î¦h¤ÖµØ¥_¡u¤¤ ­ì¤H¡v«n¾Eªº¦¨¤À¡C ¡@¡@­YS¬OµØ«n¡u­ì¦í¥Á¡vªº¦¨¤À¡AµØ«nº~¤H²§«¬Å骺¥ô¦óÀW²vAÀ³¸Ó¦³¦p¤U¹Ï«Y¡G A¡×µØ«n¤Ö¼Æ¥Á±ÚÀW²vxS¡ÏµØ¥_¡u¤¤­ì¤H¡vÀW²vx(1¡ÐS) Ä´¦p¥Î·HªùºÖ¦Ñ¤HGm1, 3, 5ªºÀW²v¬°¨Ò¡AÀ³¦³¦p¤Uªº¼Æ¾Çµ{¦¡¡G ¡@¡@¡@ 0.646¡×0.788xS ¡Ï0.257x (1¡ÐS)¡A«h S¡×0.73 ¡@¡@¥Î¦¹µ{¦¡¤]¥iºâGm1,21¤ÎGm1¡BGm1,2,21¡A¨äµ²ªG¦C¥X¦bªí¤E¡C­Y¥uºâ¥­§¡«n ¥_ÀW²v«D±`©T©w»¼´î©Î»¼¥[ªºGm1,21¤ÎGm1,3,5«hºÖ¦{¡B·Hªù¡B±ö¿¤¡B¼s¦{¥|¦a¤À §O¦³65%¡B65%¡B68%¡B92%µØ«n¡u­ì¦í¥Á¡v¦å·½ªº¦¨¤À¡A­Y¦A¥[¤W¨ä¥L¤GºØÀW²v ­pºâ¥­§¡¡A¤´¦³Ãþ¦üªºµ²ªG¡A¥|¦a¤À§O¬O60%¡B78%¡B80% ¡B86%¡C Matsumoto¼Æ¾Ú[4]¤¤¨S¦³¸ò¥xÆW¤H¸û¦³±K¤ÁÃö«Yªº»Ô«nªººÖ¦Ñ¤H¡B©Î¸f ªFªº«È®a¤H¡A¥u¦³ºÖ¦{¡B¼s¦{ªº¼Æ¾Ú¡C±q»¯®ä­Zµ¥[5,6]ªº¼Æ¾Ú¬Ý¨Ó¡AºÖ¦Ñ¤Î«È ®a¤HÀW²v¦bºÖ¦{¡B¼s¦{¤§¶¡¡C¥Î¤W­z¬Û¦P¤èªk­pºâ¡AºÖ¦{¤H¦³65%(­Y¥u¥ÎGm(ag) ¡BGm(atb1b3)ÀW²v)¡A¤Î66%(­Y¥Î¥|ºØÀW²v)¡A¼s¦{¤H«h¤À§O¦³67%¤Î73%ªºµØ«n ¡u­ì¦í¥Á¡vªº¦¨¤À[ªí¤E]¡C³o¦¨¤À¸ò»¯®ä­Zµ¥ªºÃþ¦ü¡C¨â²Õªº¬ã¨s¥i»¡¦³¤@¼Ë ªº¤º²[¡R±q§K¬Ì²y³J¥Õ²§«¬Åé¬Ý¨ÓµØ«nº~¤H¬O·½¦ÛµØ«nªº¡u­ì¦í¥Á¡v¦¨¤À»·¤ñ µØ¥_ªº¡u¤¤­ì¤H¡v¦h±o¦h¡C ¡@¡@­Y¸Ô¬Ýªí¤KMatsumotoªº¼Æ¾Ú¡A¤ñ¸û¦UºØ²§«¬Åé²Õ¦XªºÀW²v®É¡A¥xÆWº~¤Hªº Gm(ag)¤ñµØ«n°ª¦ÓGm(afb1b3)¤ñµØ«nº~¤H§C¡A¦P¼Ë¦aGm(ab3st)¤]¤ñµØ«nº~¤H°ª¦Ó Gm(axg)¤ñµØ«nº~¤H§C¡C¤]³\°¨¤W·|ÃhºÃ¬°¦ó¥xÆWº~¤H¤ñµØ«nº~¤H¦³§ó¦hªºµØ¥_ ¡u¤¤­ì¤H¡vªº¦¨¤À¡C¦ý­Y²Ó¬ÝµØ«n¤Ö¼Æ¥Á±Ú¤Î¥xÆW­ì¦í¥Áªº¦UºØÀW²v¤]³\´N¥i ¤F¸Ñ¨ä­ì¦]¡AµØ«n¤Ö¼Æ¥Á±Ú¤§Gm(ag)¤ÎGm(ab3st)¤ñ¥xÆW­ì¦í¥Á§C±o¦h¡A¦ýGm(afb1b3) ¤ÎGm(axg)¤ñ¥xÆW­ì¦í¥Á°ª¡C ¡@¡@«Ü¥i¯à¥H«e­è²¾¥Á¥xÆWªºº~¤H¸òµØ«n·í®Éªºº~¤H¦³¬Û¦PªºµØ«n¡u­ì¦í¥Á¡v ¤ÎµØ¥_¡u¤¤­ì¤H¡vªº¦¨¤À¡C¦ý³o´Á¶¡¦b¥xÆW­ì¦í¥Áº¥º¥º~¤Æ¡A­ì¦í¥Áªº°ò¦]·» ¤J¨ì²{¦b¥xÆWº~¤H¤¤¡A¦P®É¶¡¯d¦b¤¤°êªºº~¤H¤]±µ¨ü¤F§ó¦hÄ~Äòº~¤ÆªºµØ«n¡u­ì ¦í¥Á¡v¡A¦]µØ«n¡u­ì¦í¥Á¡v¤Î¥xÆW­ì¦í¥Á¤§¶¡¦UÀW²vªº¤£¦P¦Ó¨Ï¥Ø«eµØ«n¤Î¥x ÆWªºº~¤H¨âªÌ¦³¤£¬Æ¬Û¦PªºÀW²v¡C ¡@¡@¦]Gm(ag)¤ÎGm(atb1b3)¦³¸û³W«ßªº¤£¦P¡A§Ú­Ì¥i¥Î¨âºØÅܼƨӰOºâ¥Ø«e¥xÆW ¤H¦U±Ú¸sªº¦¨¤À¡C­YS=µØ«n¡u­ì¦í¥Á¡vªº¦¨¤À¡AN=µØ¥_¡u¤¤­ì¤H¡vªº¦¨¥÷¡A¥x ÆW­ì¦í¥Á¦¨¤À«h¬O(1¡ÐS¡ÐN)¡A¨º»ò¥i¥Î¼Æ¾Çµ{¦¡°Oºâ¥Ø«e¥xÆW¤H¦U±Ú¸s¦¨¤À¦p¤U¡G ¡@¡@¡@¡@0.222¡×0.053xS + 0.417xN + 0.194x (1¡ÐS¡ÐN) ¡@¡@¡@¡@0.643¡×0.921xS + 0.270xN + 0.762x (1¡ÐS¡ÐN) «hS=0.40 ; N=0.37 ¡@¡@¨Ì¦¹­pºâ¡A¥xÆW¥Ø«eº~¤H¦³40%µØ«n¡u­ì¦í¥Á¡vªº¦¨¤À¡A37%µØ¥_ ¡u¤¤­ì¤H¡vªº¦¨¤À¤Î23%¥xÆW­ì¦í¥Áªº¦¨¤À¡C·íµM¹ï¤W­z¤×¨ä¬O¥xÆWº~¤Hªº¦U±Ú ¸s¦¨¤Àªº¦Ê¤À¤ñ¼Æ¦r­n¤p¤ß¸ÑŪ¡A¦]¬°¥xÆWªº­ì¦í¥Á¦³¤£¦P±Ú¸s¡A¦U±Ú¸s¶¡®t §O¤£¤p¡AMatsumoto¥u½Õ¬dAtyal,Bunum¤ÎPaiwan¤T±Ú¦Ó¤w¡A¬Ýªí¤T Nakajiima¤Î Ohkura[12]ªº¼Æ¾Ú¡AAmi±Ú´N»P¨ä¥L¤T±Ú¦³¬Û·í¤£¦PªºÀW²v²Õ¦X¡C¤w´X¥G®ø¥¢ªº ¥­®H±Ú¤]¥i¯à·|¦³¤£¦PªºÀW²v¡A¨ì©³·|¸ò¨º¨Ç±Ú¸û±µªñ¡A«h¤£¥i¯àª¾¹D¡A­YMa- tsumoto½Õ¬d §ó¦h¥xÆW­ì¦í¥Á±Ú ¸s¡A¨ä¥­§¡ÀW²v¥i¯à·|§ïÅÜ¡A¨ä¦¨¤À¦Ê¤À¤ñ¤]·| ²¤¦³¤£¦P¡C ªí¤E: ±q G-§K¬Ì²y³J¥Õ²§«¬Åé²Õ¦XªºÀW²v­pºâµØ«n¤Ö¼Æ¥Á±Ú¡A ¡u¤¤­ì¤H¡v¡A ¥xÆW­ì¦í¥Áªº¦¨¤À _______________________________________________________________________ µØ«n¤Ö¼Æ¥Á±Ú ¡u¤¤­ì¤H¡v ¥xÆW­ì¦í¥Á ¡]µØ«n¡u­ì¦í¥Á¡v¡^ ________________________________________________________________________ »¯®ä­Zµ¥ªº¤¤°ê¤H¼Æ¾Ú[reference 5,6] ·Hªù¡]ºÖ¦Ñ¤H¡^ 65%* 35% 78%^ 22% ±ö¿¤¡]«È®a¤H¡^ 86%* 14% 80%^ 20% ¼s¦{¡]¼sªF¤H¡^ 92%* 8% 86%^ 14% ºÖ¦{ 65%* 35% 60%^ 40% Matsumotoªº¼Æ¾Ú[4] ºÖ¦{ 65%* 35% 66%^ 34% ¼s¦{ 67%* 33% 73%^ 27% ¥xÆW 40%# 37% 23% _______________________________________________________________________ * ¥u­pºâGm1,21(ag)¤ÎGm1,3,5(afb1b3)ªº¥­§¡ ^ ­pºâ¥|ºØ²Õ¦Xªº¥­§¡ # Gm1,21(ag)¤ÎGm1,3,5(afb1b3)¤@°_ºâ¡A½Ð¬Ý°Q½× ¨ä¥L¥Íª«¾Çªº¼Æ¾Ú¸ò§K¬Ì²y³J¥Õªº¬ã¨sµ²ªG¤@¼Ë¡A¥H«e¦b¥»¥Z³ø¾É¡u±q¸² µå¿}¤»ÁC»Ä¥h²B»Ã¯À¬Ý¥xÆW±Ú¸sªº¦å½t¡v[16]¤@¤å´N«ü¥X¡A¥xÆWº~¤H¦³10%¥H¤W ¥u¦³¥xÆWº~¤H¦³¡A¦Ó¤¤°êµØ«nº~¤H¤Î¤Ö¼Æ¥Á±Ú¨S¦³ªº¬ðÅÜÅé¡A³o¬ðÅÜÅéÅãµM¨Ó¦Û ¥xÆWªº­ì¦í¥Á¡A¦]¬°³oºØ¬ðÅÜÅé¦b¥xÆW­ì¦í¥Á¤Îµá«ß»«¤H¤£¤Ö¡C¥xÆWº~¤H¥D­nªº ¬ðÅÜÅ餴¸òµØ«nªºº~¤H¤ÎµØ«n¤Ö¼Æ¥Á±Ú¤j³¡¤À¬Û¦P¡AµØ¥_¤H«D±`¤Ö¤H¦³³o¨Ç¬ðÅÜ Åé¡C¦a¤¤®ü«¬³h¦åªº¬ðÅÜÅé¤]¤@¼Ë¡A¥xÆW¤ÎµØ«nªºº~¤H¤ÎµØ«n¤Ö¼Æ¥Á±Ú¦³¤£¤Ö¤@ ¼Ëªº¬ðÅÜÅé[17]¡AµØ¥_¤H¤]¤@¼Ë¦a·¥¤Ö¤H¦³¡C ¡@¡@¤HÃþ²O¤Ú²y§Ü­ì(HLA)¦³§ó¦hªº¸ê®Æ¡A¤¤°êªºHLA¸ê®Æ[18]Åã¥ÜµØ«n­]±Ú¥¬¨Ì±Ú ¸ò«n¤èº~¤HÃþ»E¡A¦Ó¥_¤èº~¤H«h»P¥_¤è»X¡Bº¡¡BÂûE¬°¤@Ãþ¡C³¯¥ú©M[19]¥Î¤¤°êªº HLA¸ê®Æ¤ÀªR¡A¤]µo²{¤@¼Ëµ²ªG¡AµØ«nº~¤H¸ò¾Fªñ¤Ö¼Æ¥Á±Ú¤ñ¸û¿Ë¡A¸ò¸û»·ªºµØ«n º~¤H¸û²¨»·¡AµØ¥_´N¨S¦p¦¹²{¶H¡C¥L´£¥X©Ò¿×­Ý¨Ö¤Î¿Ä©M»¡¡A¤Ö¼ÆµØ¥_¤H¤J«IµØ«n¡A ¤J«IªÌ³Q±µ¨ü¡A¦h¼Æ­ì¦í¥Á¤Ï³Q¦P¤Æ(º~¤Æ)¦Ó³à¥¢¦Û¤vªº»{¦P¡C¥xÆW[20]¤Î¤¤°ê[18, 19]HLAªº¸ê®Æ³£¤@¼ËÅã¥Üº~¤H¦³¨â°_·½¡CªLº¿§Qµ¥[21]³Ìªñ¤ÀªR¥xÆW¤H¦U±Ú¸sHLA¡A ¥L­Ì ±Àºâ¥X«È®a¤ÎºÖ¦Ñ¥xÆW¤H¦³13%¥xÆW­ì¦í¥Á¦å²Î¡C ¡@¡@¨ä¥L¥Íª«¾Ç¸ê®Æ¥Î«Ü¦h¤£¦PHLA¡B»Ã¯À¡B³J¥Õ½è¥H¤Î¨ä¥L¥Íª«¾Ç¸ê®Æ¤ÀªR¡A Cavili-Sforzaµ¥¤T¤Hªº¥¨µÛ¡qThe History and Geography of Human Genes¡r[22] ¤]«Ü©úÅã«ü¥X¨È¬w¤H¥]¬A¤¤°ê¤Hªºº~¤H¦³«n¥_¨â°_·½¡C³ÌªñChu et al[23]¥Î Microsatellites¬ã¨sDNA¡A¤]¦³Ãþ¦ü«n¥_¨â°_·½ªºµ²½× ¡C ±q¾ú¥v¸ê®Æ¡B»y¨¥¾Ç¤ÎªÀ·|¾Ç½Õ¬d¨Ó¤ÀªR¡A¤wº¥º¥¦h½×µÛ±j½ÕµØ«n¤Ö¼Æ ¥Á±Ú¬OµØ«nº~¤Hªº¤@¤j¨Ó·½¡A¦Ó¥xÆW­ì¦í¥Á¤]º¥³Q»{¦P¬O¬O¥xÆWºÖ¦Ñ¤Î«È®a¤H¯ª ¥ý¤§¤@³¡¤À¡AÁöµM¤´¦³¨ì©³¦¨¤À¦³¦h¤Öªºª§½×¡C³Ìªñ°ê»Ú¤W¤×¨ä±q»y¨¥¾Ç¤W¡A«Ü ¦h¤H°Q½×¥xÆW­ì¦í¥Á¥i¯à¬O«n®q¥Á±Úªº°_·½¦a¡A¥Ñ¥xÆW¤À´Á²¾¦V¤Ó¥­¬v¦U®qÀ¬[24, 25]¡A§K¬Ì²y³J¥Õªº²§«¬Åé¬ã¨s¤]¦³¨Ç¸ê®Æ¥i¯à¥i¥H¦õµý¡C³o¨Ç¤H¤å¸ê®Æªº¤ÀªR¥H ¤Î¥xÆW­ì¦í¥Áªº¨Ó·½¤ÎÂX´²µ¥ªº°ÝÃD¡A«D¥»¤å­n±´°Qªº¡Aµ¥¥H«á¸ê®Æ¦¬¶°±o§ó¦h¡A ¦A¥t¤å¨Ó¦h¦h°Q½×¡C ¡]¤­¡^µ²½×¡ @¡@ Á`¤§±q§K¬Ì²y³J¥ÕªºÃҾڬݨӡA¸ò¨ä¥L¥Íª«¾Çªº¼Æ¾Ú¤@¼Ë¡A¥x ÆW¤H°£¤F¾Ô«á·¥¤Ö¼ÆµØ¥_¥X¥Íªº·s¦í¥Á¥~¡A¥D­n¬O·½¦Û«n¨Èªº±Ú¸s¡A·½¦ÛµØ¥_ªº ¦¨¤À¸û¤Ö¡C¥xÆWªººÖ¦Ñ¤Î«È®a¤H³£¦³¨Ç¤S¤£«Ü¤Öªº¥xÆW­ì¦í¥Áªº¦å²Î¡A«È®a¸òºÖ ¦Ñ¥xÆW¤H¯ª¥ý¤G¡B¤T¦Ê¦~¨Ó±q»Ô«n¡B¸fªF²¾¥Á¨ì¥x¡A´Á¶¡¥xÆW­ì¦í¥Á¯ª¥ýº¥º¥º~ ¤Æ·»¤J¬°ºÖ¦Ñ«È®a¤H¡A¥Ñ©ó¨Ó¦Û¤¤°êªº²¾¥Á¤H¼Æ¥iÆ[¡A¥xÆW­ì¦í¥Á¯ª¥ý¦¨¤À¸û¤Ö¡C ¦P¤@®É¶¡¤º¡A§ó¦hªºµØ«n¤Ö¼Æ¥Á±Ú¡]­ì¦í¥Á¡^Ä~Äòº~¤Æ¦¨º~¤H¡A¨ä¦å²Î¤]¤@¼Ë·» ¤JµØ«nªºº~¤H¤¤¡A¥Ñ©ó¥xÆW­ì¦í¥Á»PµØ«n¤Ö¼Æ¥Á±Ú§K¬Ì²y³J¥Õ²§«¬ÅéÀW²vªº¤£¦P¡A ©Ò¥H¾É¦ÜµØ«n¤Î¥xÆWº~¤HªºÀW²v¤]¦³®t²§¡C ¡] §@ªÌ«D±`·PÁ¦¨¥\¤j¾ÇÂå¾Ç°|¤p¨à¬ì¤p¨à§K¬Ì¾Ç®aÁ©_¼ýÂå®vªº·N¨£¤ÎÀ°¦£¡^ ¡]¤»¡^°Ñ¦Ò¤åÄm 1) ù­»ªL¡R«È®a¬ã¨s¾É½×¡C 1992; ¥x¥_¡A«n¤Ñ®Ñ§½.¡]1933¿³¹çªìª©¼v¦L¥»¡^ 2) ¦¿¹B¶Q¡Rº~±Ú¥G¡H«È±Ú¥G¡H«È®aÂø»x¡C1997 (6)¡F84´Á¡R55-57. 3) Kiang C: The Hakka Odyssey and Their Taiwan Homeland. 1992; Elgin, PA, Allegheny Press. 4) Matsumoto H, Characteristics of Mongoloid population and immunogenetics of various diseases based on the genetic markers of human immunoglobulins. Expl Cli Immunogenet 1989; 6:68-87. 5) Zhao T, Lee TD: Gm and Km allotypes in 74 Chinese populations: a hypothesis of the origin of the Chinese nation. Hum Genet. 1989; 83:101-110. 6) »¯ ®ä ­Z ¡B±i ¤u ±ç ¡B ¦¶ ¥Ã ©ú µ¥ ¡A ¤¤ °ê ¤H §K ¬Ì ²y ³J ¥Õ ¦P ºØ ²§ «¬ªº ¬ã ¨s ¡R ¤¤ µØ ¥Á ±Ú °_ ·½ ªº ¤@ ­Ó°²»¡. ¿ò ¶Ç ¾Ç ³ø. 1991; 18:97-108. 7) Foster EA,Jobling MA, Taylor PG et al. Jefferson fathered slave ’ last child. Nature 1998; 396:27-28. 8) DeLange GG: Polymorphisms of Human Immunoglobulins: Gm,Am,Em and Km allotypes. Expl Clin Immunogenet.1989; 6:7-17. 9) De Lange G, Zhong F-M, Henke J et al. Immunoglobulin allotypes in a Chinese population: comparison of haplotype frequencies with other Asian groups. J Immunogenet.1991;12:191-195. 10) Schanfield MS, Gershowitz H, Ohkura K et al: Studies on the immunoglobulin allotypes of Asiatic populations. II Gm and Inv allotypes in Chinese. Hum Hered. 1972; 22:138-143. 11) Tran MH, Daveau M, Dumitresco SM et al: Immunoglobulin Gm and Km genetic markers in Vietnamese. Hum Hered.1978; 28:435-444. 12) Nakajima H, Ohkura K: the distribution of several serological and biochemical traits. III. The distribution of gamma-globulin and Gc groups in Taiwan and Ryukyu. Human Hered.1971; 21:362-370. 13) Matsumoto H, Miyazaki T, Lin JY: Gmand Km allotypes of the Taiwanese. Jap J Hum Genet.1975; 20:169-173. 14) Matsumoto H, Miyazaki T, Fong JM et al: Gm and Km allotypes of the Takasago tribes in Taiwan. Jap J Hum Genet. 1972; 17: 27-37,1972. 15) ¼B¾Çºa¡R¤¤µØ¤H¥Á¦@©M°ê¦a¹Ï. 1991¡F¥_¨Ê¡A·sµØ®Ñ©±¥_¨Êµo¦æ©Ò. 16) ¦¶¯u¤@: ±q¸²µå¿}¤»¿M»Ä¥h²B»Ã¯À¥xÆW±Ú¸sªº¦å½t¡C¥xÆWÂå¬É . 1999¡F42:252-256. 17) Ko T-M, Xu X: Molecular study and prenatal diagnosis of alpha- and beta- thalassemias in Chinese. J Formos Med Assoc. 1998; 97:5-15. 18) ³¯¤¯³C¡A¸­®ÚÅD¡A©°Âí«°µ¥¡R§Ú°ê¤j³°¥D­n¤Ö¼Æ¥Á±ÚHLA¦hºA©Ê»EÃþ¤ÀªR©MÀW²v ¤À¥¬¹ï¤¤µØ¥Á±Ú°_ ·½ªº±Ò¥Ü¡C¿ò¶Ç¾Ç³ø¡C1999¡F 20:389-398. 19) Chen KH, Genetic finding and Mongloloid population migrationin China. Bull Instit Ethnol, Academic Sinica.1992; 73:209-32. 20) Shaw C-K, Chen LL, Lee A et al: Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens. 1999; 53: 51-64. 21) Lin M, Chu CC, Lee HL et al: Heterogeneity of Taiwan indigenous population: possible relation to prehistoric Mongoloid dispersals. Tissue Antigens. 2000; 55:1-9. 22) Cavalli-Sforza LL, Menozzi P, Piazza A: The History and Geography of Human Genes. 1994; Princeton, Princeton University Press. 23) ) Chu JY, Huang W, Kuang SQ et al: Genetic relationship of population in China. Proc Natl Acad Sci. 1998; 95:11763-11768. 24) Bellwood P: The Austronesian dispersal and the origin of languages. Sci Am. 1991;265,88-93. 25) Gray RD, FM Jordan: Language trees support the express-train sequence of Austronesian expansion. Nature. 2000, 405:1052-1055. Link to: TAIWAN SPECIAL PUBLICATION ¥x ÆW ±M ¥Z Link to: HAKKA TAIWANESE SPECCIAL PUBLICATION «È ¥x »y ±M ¥Z ¦U ´Á Link to:TAIWANESE HAKKA ¥x ÆW «È ®a (ENGLISH) Link to:HAKKA TAIWANESE RESOURCES «È ¥x »y ¸ê ®Æ ®w Link to:HAKKA TAIWANESE HAKKA CULURE ¥x ÆW «È ®a ¤å ¤Æ ±M ¥Z Link to:TAIWANESE MEDICAL COMMUNITY ¥x ÆW ¤H Âå ¾Ç ¬É ±M ¥Z